What is your preferred adjuvant regimen in upper tract urothelial carcinoma patients with GFR in the 40-50 range and positive circulating tumor DNA?
What is your preferred adjuvant regimen in upper tract urothelial carcinoma patients with GFR in the 40-50 range and positive circulating tumor DNA? | Mednet
